HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen.

Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a fatal disease with a very poor 5-year survival rate. alpha-Enolase is a glycolytic enzyme that also acts as a surface plasminogen receptor. We find that it is overexpressed in PDAC and present on the cell surface of PDAC cell lines. The clinical correlation of its expression with tumor status has been reported for lung and hepatocellular carcinoma. We have previously demonstrated that sera from PDAC patients contain IgG autoantibodies to alpha-enolase. The present work was intended to assess the ability of alpha-enolase to induce antigen-specific T cell responses. We show that alpha-enolase-pulsed dendritic cells (DC) specifically stimulate healthy autologous T cells to proliferate, secrete IFN-gamma and lyse PDAC cells but not normal cells. In vivo, alpha-enolase-specific T cells inhibited the growth of PDAC cells in immunodeficient mice. In 8 out of 12 PDAC patients with circulating IgG to alpha-enolase, the existence of alpha-enolase-specific T cells was also demonstrated. Taken as a whole, these results indicate that alpha-enolase elicits a PDAC-specific, integrated humoral and cellular response. It is thus a promising and clinically relevant molecular target candidate for immunotherapeutic approaches as new adjuvants to conventional treatments in pancreatic cancer.
AuthorsPaola Cappello, Barbara Tomaino, Roberto Chiarle, Patrizia Ceruti, Anna Novarino, Carlotta Castagnoli, Paola Migliorini, Giovanni Perconti, Agata Giallongo, Michele Milella, Vladia Monsurrò, Stefano Barbi, Aldo Scarpa, Paola Nisticò, Mirella Giovarelli, Francesco Novelli
JournalInternational journal of cancer. Journal international du cancer (Int J Cancer) Vol. 125 Issue 3 Pg. 639-48 (Aug 1 2009) ISSN: 1097-0215 [Electronic] United States
PMID19425054 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Neoplasm
  • Antigens, Neoplasm
  • Immunoglobulin G
  • Interferon-gamma
  • Phosphopyruvate Hydratase
Topics
  • Animals
  • Antibodies, Neoplasm (immunology)
  • Antibody Formation
  • Antigens, Neoplasm (immunology)
  • Blotting, Western
  • Carcinoma, Pancreatic Ductal (enzymology, immunology)
  • Cell Line, Tumor
  • Cell Proliferation
  • Dendritic Cells (immunology)
  • Gene Expression Regulation, Enzymologic
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunity, Cellular
  • Immunoglobulin G (blood)
  • Immunohistochemistry
  • Interferon-gamma (secretion)
  • Keratinocytes (immunology)
  • Mice
  • Pancreas (enzymology, immunology)
  • Pancreatic Neoplasms (enzymology, immunology)
  • Phosphopyruvate Hydratase (immunology, metabolism)
  • Skin (cytology)
  • T-Lymphocytes (immunology)
  • T-Lymphocytes, Cytotoxic (immunology)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: